343 related articles for article (PubMed ID: 37753228)
1. Withaferin A: A Dietary Supplement with Promising Potential as an Anti-Tumor Therapeutic for Cancer Treatment - Pharmacology and Mechanisms.
Xing Z; Su A; Mi L; Zhang Y; He T; Qiu Y; Wei T; Li Z; Zhu J; Wu W
Drug Des Devel Ther; 2023; 17():2909-2929. PubMed ID: 37753228
[TBL] [Abstract][Full Text] [Related]
2. Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors.
Lee J; Hahm ER; Marcus AI; Singh SV
Mol Carcinog; 2015 Jun; 54(6):417-29. PubMed ID: 24293234
[TBL] [Abstract][Full Text] [Related]
3. Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
Xia S; Miao Y; Liu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2363-2369. PubMed ID: 29966656
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A suppresses the up-regulation of acetyl-coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model.
Li W; Zhang C; Du H; Huang V; Sun B; Harris JP; Richardson Q; Shen X; Jin R; Li G; Kevil CG; Gu X; Shi R; Zhao Y
Mol Carcinog; 2016 Nov; 55(11):1739-1746. PubMed ID: 26472150
[TBL] [Abstract][Full Text] [Related]
5. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells.
Szarc vel Szic K; Op de Beeck K; Ratman D; Wouters A; Beck IM; Declerck K; Heyninck K; Fransen E; Bracke M; De Bosscher K; Lardon F; Van Camp G; Vanden Berghe W
PLoS One; 2014; 9(2):e87850. PubMed ID: 24498382
[TBL] [Abstract][Full Text] [Related]
7. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
8. Anti-cancer activity of withaferin A in B-cell lymphoma.
McKenna MK; Gachuki BW; Alhakeem SS; Oben KN; Rangnekar VM; Gupta RC; Bondada S
Cancer Biol Ther; 2015; 16(7):1088-98. PubMed ID: 26020511
[TBL] [Abstract][Full Text] [Related]
9. Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.
Wang HC; Hu HH; Chang FR; Tsai JY; Kuo CY; Wu YC; Wu CC
Phytomedicine; 2019 Feb; 53():213-222. PubMed ID: 30668401
[TBL] [Abstract][Full Text] [Related]
10. Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.
Dom M; Offner F; Vanden Berghe W; Van Ostade X
J Proteomics; 2018 May; 179():17-29. PubMed ID: 29448055
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1.
Hahm ER; Singh SV
Mol Carcinog; 2020 Oct; 59(10):1105-1115. PubMed ID: 32743846
[TBL] [Abstract][Full Text] [Related]
13. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells.
Hahm ER; Lee J; Huang Y; Singh SV
Mol Carcinog; 2011 Aug; 50(8):614-24. PubMed ID: 21432907
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A targets heat shock protein 90 in pancreatic cancer cells.
Yu Y; Hamza A; Zhang T; Gu M; Zou P; Newman B; Li Y; Gunatilaka AA; Zhan CG; Sun D
Biochem Pharmacol; 2010 Feb; 79(4):542-51. PubMed ID: 19769945
[TBL] [Abstract][Full Text] [Related]
16. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
17. Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo.
Yang H; Wang Y; Cheryan VT; Wu W; Cui CQ; Polin LA; Pass HI; Dou QP; Rishi AK; Wali A
PLoS One; 2012; 7(8):e41214. PubMed ID: 22912669
[TBL] [Abstract][Full Text] [Related]
18. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
Munagala R; Kausar H; Munjal C; Gupta RC
Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
[TBL] [Abstract][Full Text] [Related]
19. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin.
Antony ML; Lee J; Hahm ER; Kim SH; Marcus AI; Kumari V; Ji X; Yang Z; Vowell CL; Wipf P; Uechi GT; Yates NA; Romero G; Sarkar SN; Singh SV
J Biol Chem; 2014 Jan; 289(3):1852-65. PubMed ID: 24297176
[TBL] [Abstract][Full Text] [Related]
20. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
Vyas AR; Singh SV
AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
